Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 90, Issue 3, 2005, Pages

  Brooks, J M ^b   Travadi, J M ^b   Patole, S K ^a,c   Doherty, D A ^c   Simmer, K ^c  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b Women's and Children's Health Service   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

ARTERY LIGATION; ARTICLE; ASSISTED VENTILATION; AUSTRALIA; CAUSE OF DEATH; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIURETIC THERAPY; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INFANT MORTALITY; MAJOR CLINICAL STUDY; MALE; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SIDE EFFECT; STATISTICAL ANALYSIS; WATER DEPRIVATION; X RAY;

CARDIOVASCULAR AGENTS; CAUSE OF DEATH; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LIGATION; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNNECESSARY PROCEDURES; WESTERN AUSTRALIA;

EID: 17844410091     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2004.057638     Document Type: Article

References (28)

1. Redline RW, Wilson-Costello D, Hack M. Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr Res 2002;52:713-19.
2. Evans N, Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996;75:F183-6.
3. Dykes FD, Lazzara A, Ahlmann P, et al. Intraventricular haemorrhage: a prospective evaluation of etiopathogenesis. Pediatrics 1980;66:42-9.
4. Ryder RW, Shelton JD, Quinan D. Necrotising enterocolitis: a prospective multicenter investigation. Am J Epidemiol 1980;112:113-23.
5. Noerr B. Current controversies in the understanding of necrotizing enterocolitis. Part 1. Adv Neonatal Care 2003;3:107-20.
6. Fowlie PW, Davis PG. Prophylactic indometacin far preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2003;88:F464-6.
7. McGuire W, Fowlie PW. Treating extremely low birthweight infants with prophylactic indometacin. Evidence for short-term benefits only. BMJ 2002;324:60-1.
8. Little DC, Pratt TC, Blalock SE, et al. Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indometacin treatment. J Pediatr Surg 2003;38:492-6.
9. Malviya M, Ohlsson A, Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2003;(3):CD003951.
10. Lelong Ussier MC, Benoit A, Dehan M, et al. Conservative management of patent ductus arteriosus in preterm infants. Intensive Care Med 1979;5:33-6.
11. Kluckow M, Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995;127:774-9.
12. Skinner J, Alverson D, Hunter S, eds. Echocardiography for the neonatologist. London: Churchill Livingstone, 2000.
13. Skinner J. Diagnosis of patent ductus arteriosus. Semin Neonatal 2001;6:49-61.
14. Papile LA, Munsick-Bruno G, Schaefer A. Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps. J Pediatr 1983;103:273-7.
15. Donoghue D, the ANZNN. The report of the Australian and New Zealand Neonatal Network, 2000. Sydney: ANZNN, 2002.
16. The International Neonatal Network. The CRIB (Clinical Risk Index for Babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet 1993;342:193-8.
17. Stefano JL, Abbasi S, Pearlman SA, et al. Closure of the ductus arteriosus with indometacin in ventilated neonates with respiratory distress syndrome. Effects on pulmonary compliance and ventilation. Am Rev Respir Dis 1991;143:236-9.
18. Yeh TF, Thalji A, Luken L, et al. Improved lung compliance following indometacin therapy in premature infants with persistent ductus arteriosus. Chest 1981;80:698-700.
19. Gerhardt T, Bancalari E. Lung compliance in newborns with patent ductus arteriosus before and after surgical ligation. Biol Neonate 1980;38:96-105.
20. Szymankiewicz M, Hodgman JE, Siassi B, et al. Mechanics of breathing after surgical ligation of patent ductus arteriosus in newborns with respiratory distress syndrome. Biol Neonate 2004;85:32-6.
21. Farstad T, Bratlid D. Pulmonary effects of closure of patent ductus arteriosus in premature infants with severe respiratory distress syndrome. Eur J Pediatr 1994;153:903-5.
22. Van Woerkom R, Govindaswami B, Cleary J, et al. Patent ductus arteriosus ligation in very low birthweight infants: is there benefit? Pediatr Res 2001:A32.
23. Carboni MP, Ringel RE. Ductus arteriosus in premature infants beyond the second week of life. Pediatr Cardiol 1997;18:372-5.
24. Fowlie PW. Intravenous indometacin for preventing mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev 2000;(2):CD000174.
25. Schmidt B, Davis P, Moddemann D, et al. Trial of indometacin prophylaxis in preterms investigators. Long-term effects of indometacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001;344:1966-72.
26. Coombs RC, Morgan MEI, Durbin GM, et al. Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indometacin. Arch Dis Child 1990;65:1067-71.
27. Meyers R, Alpan G, Lin E, et al. Patent ductus arteriosus, indometacin and intestinal distension: effects on intestinal blood flow and oxygen consumption. Pediatr Res 1991;29:569-74.
28. Cassady G, Crouse DT, Kirklin JW, et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med 1989;320:1511-16.